Evidence map›Paper›PMID 17155928›Full record

ArticleThe Biochemical journal2007

Protein phosphorylation corrects the folding defect of the neuroblastoma (S120G) mutant of human nucleoside diphosphate kinase A/Nm23-H1.

Iulia Mocan, Florian Georgescauld, Philippe Gonin, Didier Thoraval, Laura Cervoni, Anna Giartosio, Sandrine Dabernat-Arnaud, Marc Crouzet, Marie-Lise Lacombe, Ioan Lascu

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Structure, Folding and Stability of Nucleoside Diphosphate Kinases.International journal of molecular sciences · 2020
    Review
  4. Article
  5. NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.Laboratory investigation; a journal of technical methods and pathology · 2018
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Nm23-H1/NDP kinase folding intermediates and cancer: a hypothesis.Journal of bioenergetics and biomembranes · 2006
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Iulia MocanInstitut de Biochimie et Génétique Cellulaires (UMR 5095), Université Victor Segalen Bordeaux2 and CNRS, 33077 Bordeaux Cedex, France.
Florian Georgescauld
Philippe Gonin
Didier Thoraval
Laura Cervoni
Anna Giartosio
Sandrine Dabernat-Arnaud
Marc Crouzet
Marie-Lise Lacombe
Ioan Lascu
Centre National de la Recherche Scientifique · FRInstitut de Biochimie et Génétique Cellulaires · FRSorbonne Université · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human nucleoside diphosphate (NDP) kinase A is a 'house-keeping' enzyme essential for the synthesis of nonadenine nucleoside (and deoxynucleoside) 5'-triphosphate. It is involved in complex cellular regulatory functions including the control of metastatic tumour dissemination. The mutation S120G has been identified in high-grade neuroblastomas. We have shown previously that this mutant has a folding defect: the urea-denatured protein could not refold in vitro. A molten globule folding intermediate accumulated, whereas the wild-type protein folded and associated into active hexamers. In the present study, we report that autophosphorylation of the protein corrected the folding defect. The phosphorylated S120G mutant NDP kinase, either autophosphorylated with ATP as donor, or chemically prosphorylated by phosphoramidate, refolded and associated quickly with high yield. Nucleotide binding had only a small effect. ADP and the non-hydrolysable ATP analogue 5'-adenyly-limido-diphosphate did not promote refolding. ATP-promoted refolding was strongly inhibited by ADP, indicating protein dephosphorylation. Our findings explain why the mutant enzyme is produced in mammalian cells and in Escherichia coli in a soluble form and is active, despite the folding defect of the S120G mutant observed in vitro. We generated an inactive mutant kinase by replacing the essential active-site histidine residue at position 118 with an asparagine residue, which abrogates the autophosphorylation. The double mutant H118N/S120G was expressed in inclusion bodies in E. coli. Its renaturation stops at a folding intermediate and cannot be reactivated by ATP in vitro. The transfection of cells with this double mutant might be a good model to study the cellular effects of folding intermediates.

Indexed as

Adenosine TriphosphateAmino Acid SubstitutionCatalysisCell Line, TumorDNA PrimersEnzyme ActivationHumansKineticsMutagenesis, Site-DirectedNeoplasm ProteinsNeuroblastomaNM23 Nucleoside Diphosphate KinasesNucleoside-Diphosphate KinasePhosphoproteinsPhosphorylationProtein FoldingAdenosine TriphosphateDNA PrimersNeoplasm ProteinsNM23 Nucleoside Diphosphate KinasesNME1 protein, humanNucleoside-Diphosphate KinasePhosphoproteinsRecombinant Proteins

Identifiers

PMID17155928
PMCPMC1828887
OpenAlexW2039321218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.